• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 3. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

3,8-Diazabicyclo[3.2.1]octan-2-one: A Comprehensive Overview

The compound with CAS No 143393-96-8, commonly referred to as 3,8-Diazabicyclo[3.2.1]octan-2-one (specifically the (1S,5R)-enantiomer), is a bicyclic structure that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound belongs to the class of diazabicyclooctanes, which are known for their unique bicyclic framework and potential applications in drug design.

The diazabicyclo[3.2.1]octane system is characterized by a rigid bicyclic structure with two nitrogen atoms at positions 3 and 8 of the bicyclo framework. The presence of a ketone group at position 2 further enhances its functional diversity, making it a versatile scaffold for various chemical modifications. The stereochemistry of the compound, particularly the (1S,5R) configuration, plays a crucial role in determining its physical properties and biological activity.

Recent studies have highlighted the potential of 3,8-Diazabicyclo[3.2.1]octan-2-one as a building block in medicinal chemistry. Its rigid structure and ability to form hydrogen bonds make it an attractive candidate for designing bioactive molecules with specific pharmacokinetic profiles. Researchers have explored its use in the development of ligands for G-protein coupled receptors (GPCRs), where the bicyclic framework provides an ideal platform for achieving high affinity and selectivity.

The synthesis of (1S,5R)-3,8-Diazabicyclo[3.2.1]octan-2-one involves a multi-step process that typically begins with the preparation of the corresponding bicyclic amine intermediate. Various strategies have been reported in the literature, including ring-closing metathesis and enamine-based approaches, each offering distinct advantages in terms of yield and stereochemical control.

In terms of biological activity, diazabicyclooctane derivatives have shown promise as modulators of ion channels and enzymes involved in neurological disorders. For instance, recent findings suggest that certain analogs of this compound may exhibit potent inhibitory effects on voltage-gated sodium channels, which are implicated in conditions such as epilepsy and chronic pain.

Moreover, the (1S,5R)-enantiomer has been investigated for its potential as a chiral auxiliary in asymmetric synthesis. Its ability to induce high enantioselectivity in certain reactions has made it a valuable tool for constructing complex molecular architectures with high optical purity.

From an analytical standpoint, the characterization of CAS No 143393-96-8 relies on advanced spectroscopic techniques such as NMR and mass spectrometry. These methods provide critical insights into the compound's structural integrity and stereochemical configuration, ensuring its purity and consistency for downstream applications.

In conclusion, (1S,5R)-3,8-Diazabicyclo[3.2.1]octan-2-one represents a significant advancement in the field of heterocyclic chemistry due to its unique structural features and diverse functional applications. As research continues to uncover new opportunities for this compound, it is poised to play an increasingly important role in drug discovery and chemical synthesis.

• 412042-29-6(2-Pyrrolidinecarboxamide,5-oxo-N-propyl-,(2S)-(9CI))
• 474015-27-5(2-Pyrrolidinecarboxamide,N-butyl-,(2R)-(9CI))
• 55446-83-8( )
• 57022-32-9(2,5-Piperazinedione,3-(4-aminobutyl)-,(S)-(9CI))
• 677021-11-3(2-Piperazinepropanamide,3,6-dioxo-(9CI))
• 143393-97-9((1R,5S)-3,8-diazabicyclo[3.2.1]octan-2-one)
• 21028-09-1(N-(3-(5-[3-(Acetylamino)propyl]-3,6-dioxo-2-piperazinyl)propyl)acetami de)
• 63155-83-9(5-oxo-L-propyl-L-prolinamide)
• 643755-43-5(2,5-Piperazinedione,3-(3-aminopropyl)-6-methyl-,(3S,6S)-(9CI))
• 84899-61-6((S)-N-Propylpyrrolidine-2-carboxamide)